Lykos Therapeutics is a company focused on revolutionizing mental healthcare through the development of investigational psychedelics. With a mission to make mental healthcare accessible to all, Lykos Therapeutics is breaking barriers by applying decades of evidence-based research to develop MDMA-assisted therapies for PTSD and other mental health conditions. Their innovative approaches continue to be underlined by clinical trials and significant contributions in research and development. Lykos Therapeutics is committed to positively impacting individuals, communities, and societies by inspiring change in mental healthcare.